Janus Capital (NYSE:JNS), Regeneron Pharmaceuticals (NASDAQ:REGN), Research In Motion (NASDAQ:RIMM) and Waddell & Reed (NYSE:WDR) had their ratings adjusted by analysts.
Janus Capital (JNS) is now rated new Buy at Jefferies (NYSE:JEF). They have a price target of $8 on the company.
Regeneron Pharmaceuticals (REGN) was downgraded by Citigroup (NYSE:C) from "Buy" to "Hold." They have a price target of $60 on the company.
Research In Motion (RIMM) was upgraded by Sterne Agee from "Neutral" to "Buy." They have a price target of $35 on the company.
Waddell & Reed (WDR) was rated new Buy by Jefferies. They have a price target of $34 on the company.
No comments:
Post a Comment